Patents by Inventor Mary Rose Cusimano-Reaston

Mary Rose Cusimano-Reaston has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8117047
    Abstract: A business model for a healthcare provider organization (10) (HPO) which comprises a preferred provider network (PPO) or other membership agreement that allows individuals or groups to join via a membership contract. The contract allows the HPO (10) to provide a technical component of a medical evaluation or service (16). Additionally, the HPO (10) employs or retains the services of healthcare professionals (18) who participate in and monitor an evaluation of a patient (20) who can be at a remote location from the healthcare professional. The HPO (10) provides a medical diagnostic unit (24), which is known as an EFA-2, that allows the healthcare professional to receive data that pertains to the patient (20) via a real-time communication protocol (28), or the patient data is collected and stored on an electronic storage device (30). The healthcare professional then analyzes the patient data and issues recommended treatment.
    Type: Grant
    Filed: April 16, 2007
    Date of Patent: February 14, 2012
    Assignee: Insight Diagnostics Inc.
    Inventors: Mary Rose Cusimano-Reaston, Phil Reaston
  • Publication number: 20110201904
    Abstract: An electro diagnostic functional assessment unit (EFA-2) that diagnoses age of and treats soft tissue injuries. The EFA-2 utilizes sensor(s) including EMG, Range of Motion, FCE, pinch and grip, and allows for monitoring of muscles and muscle groups to ascertain compliance, pain and function. The EFA-2 also monitors disc pathology and determines whether a person requires surgery or conservative care and, the age of the disc. Additionally, the EFA-2 monitors EEK activity and NCV, as well as invasive EMG that monitors nerve damage. Previously, with NCV the temperature and the position of electrodes would effect readings and produce false positive or false negative readings. The EFA-2 eliminates these problems by incorporating temperature sensor(s) and electrode placement sensor(s). The EFA-2 also provides direct treatment by means of ultrasound and electrical stimulation. Thus, the EFA-2 allows diagnosis any treatment by means of a single unit.
    Type: Application
    Filed: February 18, 2010
    Publication date: August 18, 2011
    Inventors: Mary Rose Cusimano Reaston, Phil Reaston